| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $59.1M | +70.0% |
| R&D Expense | $48.4M | +23.3% |
| SG&A Expense | $24.9M | +46.9% |
| Operating Income | -$26.6M | +25.2% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$26.1M | +24.1% |
| Income Tax | -$3.7M | +49.0% |
| Net Income | -$22.3M | +17.4% |
| EPS (Basic) | -$0.26 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.4M | — |
| Accounts Receivable | $30.3M | +43.3% |
| Current Assets | $125.0M | — |
| Total Assets | $421.2M | +78.0% |
| Current Liabilities | $26.0M | +5838.2% |
| Total Liabilities | $79.8M | +840.6% |
| Stockholders' Equity | $341.4M | +4619.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.6M | +36.8% |
| Capital Expenditures | $17.2M | +321.8% |
| Investing Cash Flow | -$73.3M | -1721.4% |
| Financing Cash Flow | $110.7M | +1042.0% |
| Free Cash Flow | -$20.8M | -113.0% |
| +21.2% |
| EPS (Diluted) | -$0.26 | +21.2% |